Migdal Insurance & Financial Holdings Ltd. Precigen, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$6.24 - $8.22 $499,299 - $657,731	-80,016 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$6.74 - $10.95 $334,681 - $543,733	49,656 Added 163.56%	80,016 $551,000
Q4 2020 Feb 08, 2021	BUY	$3.75 - $10.56 $113,850 - $320,601	30,360 New	30,360 $310,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

Third Security, LLC

83.5M
Shares

$70.1 Million
73.5% of portfolio
Patient Capital Management, LLC Baltimore, MD

17.9M
Shares

$15.1 Million
0.92% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

10.9M
Shares

$9.13 Million
0.02% of portfolio
Black Rock Inc. New York, NY

10.2M
Shares

$8.61 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.33M
Shares

$7 Million
0.0% of portfolio

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $175M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account